| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |